Innovation Engineered at the Intersection of Life Sciences and Finance

Launched in Switzerland in 2024, our team combines over 100 years of experience and proven expertise across clinical research, computer science, and finance.

Since 2016, we have pioneered a data-driven approach to indication finding—designed to accelerate development timelines, unlock asset value, and guide smarter, more informed strategic decisions. By integrating rigorous analytics with deep domain insights, we help life sciences partners and investors de-risk program development and navigate indication strategy with clarity and confidence.